Janus Henderson Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Sell |
|
|||||
|
2025
Q1 | $237M | Sell |
|
|||||
|
2024
Q4 | $526M | Sell |
|
|||||
|
2024
Q3 | $544M | Buy |
|
|||||
|
2024
Q2 | $603M | Sell |
|
|||||
|
2024
Q1 | $633M | Sell |
|
|||||
|
2023
Q4 | $515M | Sell |
|
|||||
|
2023
Q3 | $701M | Buy |
|
|||||
|
2023
Q2 | $624M | Buy |
|
|||||
|
2023
Q1 | $677M | Sell |
|
|||||
|
2022
Q4 | $781M | Sell |
|
|||||
|
2022
Q3 | $1.43B | Buy |
|
|||||
|
2022
Q2 | $542M | Sell |
|
|||||
|
2022
Q1 | $583M | Buy |
|
|||||
|
2021
Q4 | $652M | Sell |
|
|||||
|
2021
Q3 | $684M | Buy |
|
|||||
|
2021
Q2 | $536M | Buy |
|
|||||
|
2021
Q1 | $460M | Buy |
|
|||||
|
2020
Q4 | $661M | Sell |
|
|||||
|
2020
Q3 | $555M | Buy |
|
|||||
|
2020
Q2 | $580M | Buy |
|
|||||
|
2020
Q1 | $345M | Buy |
|
|||||
|
2019
Q4 | $409M | Buy |
|
|||||
|
2019
Q3 | $174M | Sell |
|
|||||
|
2019
Q2 | $415M | Buy |
|
|||||
|
2019
Q1 | $318M | Buy |
|
|||||
|
2018
Q4 | $201M | Buy |
|
|||||
|
2018
Q3 | $66M | Buy |
|
|||||
|
2018
Q2 | $317K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $2.15M | Buy |
|